about
Biochemical and structural insights of the early glycosylation steps in calicheamicin biosynthesisPolyketide synthase chemistry does not direct biosynthetic divergence between 9- and 10-membered enediynesBiosynthesis and function of polyacetylenes and allied natural productsSimultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.Therapeutic cancer targeting peptides.Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth.Enediyne antitumor antibiotic maduropeptin biosynthesis featuring a C-methyltransferase that acts on a CoA-tethered aromatic substrate.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles.Rapid PCR amplification of minimal enediyne polyketide synthase cassettes leads to a predictive familial classification model.Antibody therapeutics in cancer.Advances in haematological pharmacotherapy in 21st century.Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.Targeted imaging and therapy of brain cancer using theranostic nanoparticlesTargeted therapy for hematologic malignancies.Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulumPredictive model for epoxide hydrolase-generated stereochemistry in the biosynthesis of nine-membered enediyne antitumor antibiotics.Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.Site-specific antibody drug conjugates for cancer therapyTrends in cancer-targeted antibody-drug conjugates.Iterative type I polyketide synthases involved in enediyne natural product biosynthesis.Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.Antibody-Based Treatment of Acute Myeloid Leukemia.Targeted Therapy in Oncology.A genomics-guided approach for discovering and expressing cryptic metabolic pathways.Cisplatin-directed coordination-crosslinking nanogels with thermo/pH-sensitive triblock polymers: improvement on chemotherapic efficacy via sustained release and drug retention.Molecular design and synthesis of self-assembling camptothecin drug amphiphiles.
P2860
Q24621823-54F1ACE0-4324-432D-8142-F2E858ECFC2CQ24623828-E8CD820A-9AB0-42BF-BAA0-03F9551CE928Q24644952-699CA886-E574-430C-A763-C0F1EC877854Q31016741-C3CAE317-E56A-429E-A710-955322B1F98AQ33184888-82562CCC-8B23-4E0A-AC94-899CBDA5748EQ33216322-1138E4EB-FDB1-4B6B-86AB-F9630131AD52Q34112660-693115CA-BAD6-4F72-B500-42F638996F8EQ34152258-39CD2B98-3D12-4384-868B-54986117F083Q34159575-90844418-DD89-46F1-850E-6D47712AA34BQ34267723-7066D599-255A-4D8B-B262-7B626CBCDB87Q34370627-0DB9A03D-D8E5-48E4-B921-0A73CB5691C1Q34406838-22F13844-4A62-4C73-A7E8-5EAB396B2C3FQ35016589-61E2FC84-ED2E-40FB-BFB4-2DC2A571C936Q35792897-CCE75A30-1753-47DA-A352-488E75353961Q36108610-E76C9DD7-9C70-4293-9425-8F31DC7A04ABQ36438481-961B2FAD-1A5F-4B38-82E6-323B8E7BF907Q36899294-6B914AE6-95A4-4335-85B3-CCE28D15557BQ37360842-51F9ED2A-9ECB-42F3-A0D0-3D504792315AQ37370563-997A73F8-35C3-47B3-97C0-8BE58D95C7A0Q37593705-F012CC44-805A-4AC1-A485-34A36A755E0CQ38162127-922F6F36-48DF-41C6-B10F-021AE4F95E32Q38256311-6FA7D02E-67A1-4DB1-B55C-64E3BDAB6959Q38489049-0102DDEE-5603-4850-B2A9-D954EE01DB21Q38979277-78859924-8387-41F4-B47F-9DB6ACD65818Q41767276-C366D45F-CC8A-4318-A314-6C1595F03A49Q48264057-DD473748-82E5-4157-9EE1-A5FA73EA6250Q50654845-BE1DB805-54E8-4322-9783-7DA826ED6020Q50682565-BBDBAB17-1C81-4035-A6E1-DE538B5B77B9
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mylotarg: antibody-targeted chemotherapy comes of age.
@ast
Mylotarg: antibody-targeted chemotherapy comes of age.
@en
Mylotarg: antibody-targeted chemotherapy comes of age.
@nl
type
label
Mylotarg: antibody-targeted chemotherapy comes of age.
@ast
Mylotarg: antibody-targeted chemotherapy comes of age.
@en
Mylotarg: antibody-targeted chemotherapy comes of age.
@nl
prefLabel
Mylotarg: antibody-targeted chemotherapy comes of age.
@ast
Mylotarg: antibody-targeted chemotherapy comes of age.
@en
Mylotarg: antibody-targeted chemotherapy comes of age.
@nl
P1476
Mylotarg: antibody-targeted chemotherapy comes of age.
@en
P2093
Linenberger M
Sievers EL
P304
P356
10.1097/00001622-200111000-00016
P577
2001-11-01T00:00:00Z